Access the Care You Deserve with the AIMS Fund

Your Health, Our Priority

At the Advanced Integrative Medical Science (AIMS) Institute, we believe that innovative, life-changing healthcare should be available to everyone—regardless of financial circumstances. That’s why we created the Social Equity Entheogenic Care Fund, designed to provide access to advanced therapies for patients who need it most.

For patients on Medicaid, the AIMS Fund also offers an opportunity to be considered for admittance to insurance panels that are currently closed to new patients.

What the AIMS Fund Can Do for You

If you’re struggling to afford treatments or facing insurance limitations, the AIMS Fund may be able to help. This program supports patients seeking innovative therapies like:

Ketamine-Assisted Psychotherapy (KAP): A breakthrough mental health treatment for depression, PTSD, and anxiety.
Medical Cannabis Education: Guidance on safe, effective use of medical cannabis.
Advanced Intravenous Therapies: Cutting-edge treatments for chronic illness and pain.
Sympathetic Ganglion Blocks: Innovative procedures for managing chronic pain and nerve-related conditions.

Many of these treatments are considered experimental and are not covered by insurance—but with help from the AIMS Fund, they can be within your reach.

Who Can Apply?

Our financial aid program is open to patients who:

Require financial assistance to access advanced therapies.
Are on Medicaid and wish to be considered for admittance to insurance panels that are otherwise closed to new patients.
Have a medical condition that aligns with AIMS Institute’s specialized treatments.
Are committed to working with our multidisciplinary team for personalized care.

Applications from Medicaid patients will receive a response within one week, ensuring timely access to treatment options.

How It Works

Apply for Financial Aid: Submit your application on Awake.net to be considered for assistance and/or panel admittance.
Crowdfund Your Care: Use our crowdfunding platform to connect with friends, family, and community members who want to support your journey to health.
Receive Support: Funds raised through your campaign, combined with allocations from the AIMS Fund, will be used to cover the cost of your treatment.

Real Hope, Real Change

The AIMS Fund has already helped patients like you access care that changes lives. With your commitment and the support of our community, we can make healing possible.

Ready to Start?

Applying is simple. Visit Awake.net to fill out your financial aid application and set up your crowdfunding page. If you’re a Medicaid patient, your application will also be reviewed for panel admittance with a response provided within a week.

Don’t let financial barriers stop you from getting the care you need. The AIMS Fund is here to help.

Apply Now and Begin Your Healing Journey

Latest Blog Posts

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care

Healthcare Disparities in African American Communities African Americans continue to face significant disparities in healthcare. From higher mortality rates for chronic conditions like cancer and heart disease to underdiagnosis of autoimmune disorders, these inequities stem from systemic racism, implicit bias, and a lack of cultural sensitivity among providers. Studies show that Black patients are less likely to receive adequate pain management and more likely to feel unheard or dismissed during medical visits. These disparities erode trust in the healthcare system and lead to poorer outcomes and avoidable suffering. For many, navigating the system can feel isolating and disempowering, leaving them ...

At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

A recent paper in the Frontiers in Medicine states that An underutilized intervention for long COVID is low dose naltrexone, which has an established safety profile for a variety of conditions. ‘Naltrexone is a non-selective opioid antagonist currently approved by the US Food and Drug Administration (FDA) for the treatment of alcohol and opioid dependence and is prescribed at 50–150 mg daily. At doses below 5 mg, it is considered low-dose naltrexone (LDN), exhibits anti-inflammatory and analgesic properties, and has been used off-label to reduce severity of symptoms in conditions such as fibromyalgia, multiple sclerosis, complex regional pain syndrome, myalgic encephalomyelitis/chronic fatigue ...

Unusual Suspects

Psychedelic Therapies Gain New Advocates Texas Law Magazine Written by Robin Berghaus. Art by Matthieu Bourel Published November 6, 2024 Marcus Capone served seven combat tours as a Navy SEAL — including missions with SEAL Team Six, the nation’s preeminent counterterrorism unit — before being medically retired in 2013. For years, he struggled to find effective treatments for his traumatic brain injuries, depression, and post-traumatic stress disorder. Capone tried antidepressants, talk therapy, hyperbaric oxygen therapy, transcranial magnetic stimulation, and he visited several brain clinics. Nothing worked. When Capone’s life began falling apart, he considered suicide. His wife was just as ...

Fundraising Appeal for Patients with Financial Need